| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6183064 | Gynecologic Oncology | 2012 | 5 Pages |
Abstract
⺠Overexpression of synuclein-γ is a predictor for aggressive tumor behavior and adverse outcome in patients with endometrial cancer. ⺠Overexpression of synuclein-γ might play a role in the drug resistance to chemotherapy in patients with endometrial cancer. ⺠Synuclein-γ merits a future exploration in endometrial cancer research.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Paulette Mhawech-Fauceglia, Dan Wang, Susanna Syriac, Heidi Godoy, Nefertiti Dupont, Song Liu, Kunle Odunsi,